Genomic-Clinical Integration
The platform integrates genomic and molecular data with the clinical record.
Precision medicine platform development builds software that integrates genomic and molecular data with clinical data to support targeted, personalized treatment decisions. A precision medicine platform combines genomic and clinical data integration, variant annotation and interpretation support, molecular tumor board tools, evidence-based decision support, and reporting, helping clinicians match the right patient to the right therapy while experts make the decisions.
Precision medicine turns a patient’s molecular profile into more targeted care, but only if genomic and clinical data can be integrated, interpreted, and put in front of clinicians usefully. Taction Software builds precision medicine platforms that bring molecular and clinical data together and support expert decision-making, grounded in evidence and human oversight. We have delivered healthcare data and AI software since 2013, and this work builds on our broader healthcare AI development practice.

Our experts are ready to understand your business goals.






























































A precision medicine platform is software that helps clinicians use a patient’s genomic and molecular information, alongside clinical data, to guide more targeted treatment. Its foundation is data integration: bringing together next-generation sequencing and variant data with the clinical record, which is technically demanding because genomic data is large, complex, and stored in specialized formats. On top of that foundation, the platform supports variant annotation and interpretation, linking observed variants to knowledge about their significance and to potential targeted therapies or clinical trials. It often supports molecular tumor boards, where a multidisciplinary team reviews complex cases, and it provides evidence-based decision support that surfaces relevant options without making the decision. Because interpretation and treatment choices require clinical and molecular expertise, the platform informs experts rather than replacing them. Matching patients to targeted trials connects to capabilities like clinical trial matching. Done well, a precision medicine platform makes molecular insight usable at the point of care, responsibly and with strong data protection.
The platform integrates genomic and molecular data with the clinical record.
It annotates variants with knowledge about their significance.
It supports interpretation linking variants to therapies and evidence.
It supports multidisciplinary review of complex cases.
It surfaces relevant options without making the decision.
Clinical and molecular experts make the treatment decisions.
Taction Software delivers precision medicine platforms as a full engagement shaped to your program, whether you are an academic medical center, a health system precision medicine program, a molecular diagnostics lab, or a research organization. We map your data sources, workflows, and clinical goals first, then build the modules that fit: genomic and clinical data integration, variant annotation and knowledge-base integration, interpretation and reporting, molecular tumor board support, decision support, and cohort and analytics tools. Because integrating and managing complex data is the technical core, we draw on our data engineering and healthcare IT solutions practice. Where machine learning aids interpretation or prioritization, we build and maintain it responsibly with proper model operations. We design for the reality that genomic knowledge evolves constantly, so interpretation stays current. Every module is composable, so you can start with data integration and reporting and expand into tumor boards and decision support over time. The goal is a platform that makes molecular data clinically useful, evidence-based, and safe.
Integration of sequencing and variant data with the clinical record.
Annotation linking variants to curated knowledge.
Support for interpretation and clear molecular reporting.
Tools that support multidisciplinary case review.
Evidence-based surfacing of therapy and trial options.
Cohort building and analytics across the molecular population.
A purpose-built precision medicine platform delivers value that disconnected genomic reports and manual review cannot, because molecular data is only useful when it is integrated, interpreted, and actionable. The clearest benefit is usable molecular insight: integrating genomic and clinical data lets clinicians actually use a patient’s molecular profile at the point of care rather than in isolated PDFs. Interpretation and knowledge-base integration help translate raw variants into meaningful, evidence-based options. Molecular tumor board support makes complex, multidisciplinary review more efficient and better documented. Decision support surfaces relevant targeted therapies and trials that might otherwise be missed, expanding options for patients. Cohort analytics support both care and research. Because the platform keeps interpretation current as knowledge evolves, it stays useful over time rather than freezing at a moment’s understanding. For programs, a strong platform is what makes precision medicine operational at scale rather than a boutique effort. For patients, it can mean more targeted, better-informed care, with clinicians firmly in charge.
Integration makes molecular profiles usable at the point of care.
Annotation and knowledge bases translate variants into options.
Support makes complex case review efficient and documented.
Decision support surfaces therapies and trials that might be missed.
Cohort analytics support both care and research.
Interpretation stays current as genomic knowledge evolves.
Taction Software follows a compliance-first process refined across more than a decade of healthcare delivery, with particular care for sensitive genomic data. We begin with discovery, documenting your data sources, sequencing and lab systems, clinical workflows, and goals. We then design an architecture for integrating and managing large, complex molecular and clinical data, plus annotation, interpretation, tumor board, and decision-support modules, with a privacy and security model appropriate for genetic data. Development runs in iterative sprints with clinical, molecular, and bioinformatics review, because precision medicine spans disciplines and no single perspective is sufficient. We integrate knowledge bases and design interpretation to stay current as evidence evolves. Testing covers data integrity, interpretation accuracy, and workflow usability. We deploy with the oversight and validation clinical use requires, then support ongoing knowledge and model updates. Throughout, we keep experts in charge and treat genomic data with heightened protection, because genetic information is uniquely sensitive and its misuse carries lasting consequences.
We document data sources, sequencing systems, and clinical workflows.
We design data integration and a genetic-data-appropriate privacy model.
Features are built with clinical, molecular, and bioinformatics review.
We integrate knowledge bases and keep interpretation current.
We validate data integrity, interpretation accuracy, and usability.
We deploy with oversight and support ongoing knowledge updates.
Precision medicine platforms handle large, complex, and uniquely sensitive genomic data and support clinical decisions, so data engineering, security, and evidence rigor are foundational. Taction Software builds on a HIPAA-aligned foundation, with encryption in transit and at rest, granular access controls, audit logging, and Business Associate Agreements where applicable, and we apply heightened protection to genetic data, mindful of privacy laws and the lasting sensitivity of genomic information. Our architecture handles large molecular datasets on healthcare-grade cloud, and supports standards-based interoperability including HL7, FHIR, and FHIR Genomics so molecular and clinical data connect. We integrate curated knowledge bases and design interpretation to stay current as evidence changes. Where machine learning aids interpretation or prioritization, we build it with validation and ongoing monitoring, aligned with our healthcare MLOps practice, and we keep it as decision support under expert control. Because treatment decisions carry real stakes, we ground the platform in evidence and expert oversight rather than automation.
Encryption, access controls, and BAAs protect clinical and molecular data.
Genomic data receives heightened protection given its sensitivity.
Healthcare-grade cloud handles large molecular datasets.
HL7, FHIR, and FHIR Genomics connect molecular and clinical data.
Knowledge bases and interpretation stay current with evidence.
Any ML is validated, monitored, and kept under expert control.
Taction Software is a US-based healthcare software company founded in 2013, with offices in Chicago, Cheyenne, Austin, and Sacramento. We build healthcare software exclusively, so complex data engineering, interoperability, and compliance are part of our default process rather than afterthoughts. We have delivered more than 200 healthcare projects, including EHR and EMR platforms such as Voyant Health, FDA-registered mobile applications, and behavioral health tools. That data depth matters in precision medicine, where integrating and managing complex molecular and clinical data is the core technical challenge. We work as a candid, long-term partner, respectful of the clinical and scientific complexity and disciplined about evidence and oversight, rather than overpromising automation in a field that demands expert judgment. Our leadership brings deep, hands-on expertise, with our CEO contributing more than 20 years of personal experience in software and healthcare technology. Building with Taction means partnering with a team that has repeatedly taken healthcare software from concept to production in regulated settings.
We build healthcare software only, so compliance and data are built into our process.
We integrate and manage complex molecular and clinical data.
Strong HL7, FHIR, and FHIR Genomics experience connects data.
We ground the platform in evidence and expert control.
US offices and US-based delivery support close collaboration and clear accountability.
We keep interpretation and models current as knowledge evolves.
Precision medicine platform pricing depends on scope, data integration complexity, and clinical features. Taction Software scopes each engagement to your program, and typical ranges are as follows. A focused module or MVP, such as genomic and clinical data integration with reporting, generally falls between $40,000 and $80,000. A full precision medicine platform with annotation, interpretation, tumor board support, decision support, and analytics typically ranges from $80,000 to $200,000. Enterprise programs with advanced interpretation, deep integration, and research capabilities start at $200,000 and up. Because molecular data integration is technically demanding, we scope it explicitly. Final pricing follows a discovery phase that defines data, workflows, and features. We provide clear, itemized estimates so you can build a data foundation first and expand into clinical capabilities.
Genomic and clinical data integration with reporting typically ranges from $40,000 to $80,000.
A complete precision medicine platform typically ranges from $80,000 to $200,000.
Advanced, research-capable platforms start at $200,000 and up.
Data integration complexity, interpretation, and clinical features drive cost.
Building the data foundation first enables clinical features to follow.
A short discovery phase produces an itemized, fixed-scope estimate before development begins.
Ready to make molecular data clinically useful for targeted, personalized care? Taction Software will map your data and workflows, scope the right build, and deliver a HIPAA-compliant precision medicine platform on a realistic timeline. Contact us to schedule a discovery call and receive an itemized estimate.
A precision medicine platform is software that integrates genomic and molecular data with clinical data to support targeted, personalized treatment decisions. It combines data integration, variant annotation and interpretation support, molecular tumor board tools, evidence-based decision support, and reporting, helping clinicians match patients to appropriate therapies while experts make the decisions.
The platform integrates a patient’s molecular profile with clinical data, annotates variants with curated knowledge, and surfaces relevant evidence-based options such as targeted therapies and trials. It supports molecular tumor boards and decision-making, but clinical and molecular experts always make the treatment decisions.
Genomic data is uniquely sensitive, so Taction Software applies heightened protection: encryption, strict access controls, audit logging, and privacy design mindful of genetic-information laws. Because genetic data cannot be changed if exposed, we treat its protection as a core requirement throughout the platform.
A properly built precision medicine platform is HIPAA-compliant, and Taction Software includes encryption, access controls, audit logging, and Business Associate Agreements, with additional protection for genetic data. Because the platform handles clinical and molecular data, compliance and privacy are engineered into the architecture.
Cost depends on scope. Genomic and clinical data integration with reporting typically ranges from $40,000 to $80,000, a full platform from $80,000 to $200,000, and advanced research-capable platforms start at $200,000 and up. A discovery phase produces an itemized estimate.
Timelines vary with scope and data complexity. A focused integration-and-reporting module can reach production in a few months, while a full platform with interpretation and tumor board support takes longer. Taction Software works in iterative sprints so you build a foundation and expand.
Your email address will not be published. Required fields are marked *
Our expert reaches out shortly after receiving your request and analyzing your requirements.
If needed, we sign an NDA to protect your privacy.
We request additional information to better understand and analyze your project.
We schedule a call to discuss your project, goals. and priorities, and provide preliminary feedback.
If you're satisfied, we finalize the agreement and start your project.